Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
View Patent ↗The present invention relates to a contrast-enhanced diagnostic imaging method for monitoring the efficacy of interventional therapies. The contrast agents useful in this method comprise an image-enhancing moiety (IEM) and a state-dependent tissue binding moiety (SDTBM). These contrast agents exhibit state-dependent binding to one or more components of a targeted tissue or tissue component and provide a detectable change in the signal characteristics of the agent once bound to the targeted tissue. As a result, these agents exhibit a binding affinity for, and thus image contrast of, the targeted tissue which changes as the tissue-state changes during therapy.
1. A method for monitoring treatment of a tissue comprising HSA for evaluating efficacy of interventional therapy in a patient, said method comprising:
a) administering a contrast agent to said patient, wherein said contrast agent is selected from the group consisting of MS-315, MS-317, MS-322, MS-323, MS-325, MS-326, MS-327, and MS-328;
b) subjecting said patient to magnetic resonance imaging to determine an initial signal intensity value in a region of interest of said undesired tissue;
c) applying an interventional therapy to at least a portion of said undesired tissue in order to treat said undesired tissue; and
d) monitoring with magnetic resonance imaging a change in said initial signal intensity value in said region of interest of said undesired tissue.
2. The method of claim 1 , wherein said tissue is selected from the group consisting of cancerous tissue, tumorous tissue, and neoplastic tissue.
3. The method of claim 2 , wherein said tissue is cancerous tissue.
4. The method of claim 1 , wherein said interventional therapy is selected from the group consisting of a thermal energy generation, a cryoablation, an injection of a denaturing liquid, an injection of a chemotherapeutic agent, and a photodynamic therapy.
5. The method of claim 4 , wherein said interventional therapy is said generation of thermal energy, and wherein said thermal energy is generated by a source selected from the group consisting of one or more focused ultrasound waves, radiofrequency waves, microwaves, and lasers.
6. The method of claim 1 , further comprising: e) stopping said interventional therapy application when said change in said initial signal intensity value in said region of interest of said undesired tissue is more than about a 10% reduction in said initial signal intensity value.